| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 |
| filingDate |
1995-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6cc5a900d2cc1ee58441c47065f1703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae6cab813235dcb402bb0baad856dbc |
| publicationDate |
1996-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5561139-A |
| titleOfInvention |
Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators |
| abstract |
Compounds having the formula <IMAGE> (I) and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R104 and R105 is hydrogen, and the other of R104 and R105 is a radical having the formula <IMAGE> (II) as well as pharmaceutically compositions containing such compounds and methods of immunomodulative therapy utilizing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7521420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10040751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005054562-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9181298-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8129561-B2 |
| priorityDate |
1993-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |